Bos, Wouter H. http://orcid.org/0000-0003-3720-793X
van Tubergen, Astrid http://orcid.org/0000-0001-8477-0683
Vonkeman, Harald E. http://orcid.org/0000-0003-3792-7718
Article History
Received: 27 October 2020
Accepted: 10 December 2020
First Online: 15 January 2021
Compliance with ethical standards
:
: Dr. Bos reports grants and personal fees from Abbvie, grants and personal fees from Eli Lilly, personal fees from Galapagos, grants and personal fees from Sanofi, grants from Celgene, grants from Pfizer, grants from Roche, grants from UCB, all outside the submitted work; Dr. van Tubergen reports grants from Pfizer, grants from Abbvie, grants from UCB, grants and personal fees from Novartis, grants from Biogen, all outside the submitted work; Dr. Vonkeman reports grants and/or personal fees for lectures and advisory boards and/or travel reimbursement from Abbvie, Amgen, AstraZeneca, BMS, Celgene, Celltrion, Galapagos, Gilead, GSK, Janssen-Cilag, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi-Genzyme, all outside the submitted work.
: The Medical Research involving Human Subjects Act did not apply to this study and therefore did not require review by a medical ethics board.
: All participants gave informed consent for the use and publication of the survey data.
Free to read: This content has been made available to all.